Views regarding the MIAME requirements range from a perception that they are insufficient 5, to opinions that any requirements to annotate public microarray data should be abandoned. One problem with ...
A major genetic analysis of over 3,200 Japanese individuals reveals a more complex ancestry than previously thought, ...
The European Bioinformatics Institute has discussed the possibility of establishing a public repository for DNA microarray-based gene expression data with many of the major laboratories developing and ...
Scientists analyzing the genomes of thousands of people across Japan discovered evidence for a previously overlooked third ...
Veradermics develops novel dermatology treatments, targeting both adult and pediatric markets with a research-driven approach ...
For sixty years, scientists told the same story about Japanese ancestry. The population descended from two ancient groups: ...
Key opportunities lie in reagents & consumables due to their high usage, drug discovery's large market share, and significant ...
Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the first quarter ended March 31, 2026. "The Bionano business is healthy, with first ...
Dr Sahil Tulsi’s groundbreaking research on genetic differences is paving the way for personalised TB treatment in South Africa.
Pregnancy care is now being transformed from its traditional, observational monitoring approach into a proactive, ...
U.S. Genomic Medicine Market was valued at USD 9.93 billion in 2025 and is expected to reach USD 32.9 billion by 2035 owing to the increasing use of personalized medicineAustin, May 14, 2026 (GLOBE ...
SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the first quarter ended March 31, 2026.